<DOC>
	<DOCNO>NCT00275756</DOCNO>
	<brief_summary>Background Autoregulation ability vascular bed maintain blood flow despite change perfusion pressure . The existence effective autoregulation optic nerve circulation show animal human . The exact mechanism behind autoregulation still unknown . The motive investigation optic nerve head ( ONH ) blood flow autoregulation enhance understand pathologic eye condition associate ocular vascular disorder . To clarify regulatory mechanism ONH microcirculation critical importance understand pathophysiology glaucoma , evidence glaucoma associate optic nerve head ischemia . Several study indicate disturb autoregulation might contribute glaucomatous optic neuropathy . Currently , five class intraocular pressure ( IOP ) reduce drug available topical therapy patient glaucoma elevate intraocular pressure . These drug also vasoactive property , may influence rest ocular circulation autoregulatory mechanism blood flow change ocular perfusion pressure . Study objective To investigate influence common topical glaucoma therapy ONH blood flow regulation change IOP systemic arterial blood pressure .</brief_summary>
	<brief_title>Effects Common Topical Glaucoma Therapy Optic Nerve Head Blood Flow Autoregulation During Increased Arterial Blood Pressure Artificially Elevated Intraocular Pressure Healthy Humans</brief_title>
	<detailed_description />
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Dorzolamide</mesh_term>
	<mesh_term>Brimonidine Tartrate</mesh_term>
	<mesh_term>Timolol</mesh_term>
	<criteria>Men age 19 35 year , nonsmoker Body mass index 15th 85th percentile Normal finding medical history physical examination unless investigator considers abnormality clinically irrelevant Normal ophthalmic finding , ametropia &lt; 1 Dpt . Regular use medication , abuse alcoholic beverage , participation clinical trial 3 week precede study Treatment previous 3 week drug Symptoms clinically relevant illness 3 week first study day Blood donation previous 3 week Presence intraocular pathology : ocular hypertension , glaucoma , retinal vasculopathy retinal disease</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>Ocular Physiology</keyword>
	<keyword>Brimonidine</keyword>
	<keyword>Timoptic</keyword>
	<keyword>Dorzolamide</keyword>
	<keyword>ocular blood flow</keyword>
	<keyword>Regional Blood Flow</keyword>
</DOC>